Knights of Columbus Asset Advisors LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1688666 NEW HAVEN, CT

Position in VRDN

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,296,058

+$165,706 QoQ

Shares Held

70,553

+22.1% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#98

of 215 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Knights of Columbus Asset Advisors LLC holds $27,324,036 across 16 Biotechnology names. VRDN ranks #14 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	14,071	$3,444,158
2	MIRM	Mirum Pharmaceuticals, Inc.	23,831	$2,789,895
3	KYMR	Kymera Therapeutics, Inc.	18,313	$2,099,951
4	RYTM	Rhythm Pharmaceuticals, Inc.	18,043	$2,003,314
5	COGT	Cogent Biosciences, Inc.	50,156	$1,941,037
6	IDYA	IDEAYA Biosciences, Inc.	47,328	$1,763,914
7	DNLI	Denali Therapeutics Inc.	67,591	$1,738,440
8	EWTX	Edgewise Therapeutics, Inc.	38,641	$1,569,983

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,296,058	70,553	+22.1%	Shares	Sole	2026-07-31
2026-03-31	$1,130,352	57,789	-0.4%	Shares	Sole	2026-05-11
2025-12-31	$1,805,769	58,026	-2.3%	Shares	Sole	2026-02-09
2025-09-30	$1,282,067	59,410	+2.4%	Shares	Sole	2025-11-03
2025-06-30	$811,175	58,024	-2.1%	Shares	Sole	2025-07-22
2025-03-31	$799,107	59,281	+2.7%	Shares	Sole	2025-05-07
2024-12-31	$1,106,319	57,711	+0.3%	Shares	Sole	2025-02-11
2024-09-30	$1,309,603	57,565	-28.0%	Shares	Sole	2024-11-12
2024-06-30	$1,040,461	79,974	+1.5%	Shares	Sole	2024-07-30
2024-03-31	$1,380,173	78,822	-48.8%	Shares	Sole	2024-05-10
2023-12-31	$3,353,009	153,949	+420.9%	Shares	Sole	2024-01-31
2023-09-30	$453,343	29,553	+2.9%	Shares	Sole	2023-11-01
2023-06-30	$683,486	28,730	—	Shares	Sole	2023-08-01
No filing history on record for this holder in this stock.